» Articles » PMID: 37700002

Combined Dandelion Extract and All-trans Retinoic Acid Induces Cytotoxicity in Human Breast Cancer Cells

Overview
Journal Sci Rep
Specialty Science
Date 2023 Sep 12
PMID 37700002
Authors
Affiliations
Soon will be listed here.
Abstract

Breast cancer is one of the most prevalent and deadly cancers among women worldwide. Recently, natural compounds have been widely used for the treatment of breast cancer. Present study evaluated antiproliferative and anti-metastasis activities of two natural compounds of dandelion and all-trans-retinoic acid (ATRA) in human MCF-7 and MDA-MB231 breast cancer cells. We also evaluated the expression of MMP-2, MMP-9, IL-1β, p53, NM23 and KAI1 genes. Data showed a clear additive cytotoxic effect in concentrations of 40 μM ATRA with 1.5 and 4 mg/ml of dandelion extract in MCF-7 and MDA-MB231 cells, respectively. In both cell lines, compared with the untreated cells, the expression levels of MMP-9 and IL-1β were significantly decreased while p53 and KAI1 expression levels were increased. Besides, MMP-2 and NM23 had different expressions in the two studied cell lines. In conclusion, dandelion/ATRA co-treatment, in addition to having strong cytotoxic effects, has putative effects on the expression of anti-metastatic genes in both breast cancer cells.

Citing Articles

Botany, Traditional Use, Phytochemistry, Pharmacology and Quality Control of : Comprehensive Review.

Wu J, Sun J, Liu M, Zhang X, Kong L, Ma L Pharmaceuticals (Basel). 2024; 17(9).

PMID: 39338278 PMC: 11434673. DOI: 10.3390/ph17091113.


Potential Anti-Tumorigenic Properties of Diverse Medicinal Plants against the Majority of Common Types of Cancer.

Albahri G, Badran A, Abdel Baki Z, Alame M, Hijazi A, Daou A Pharmaceuticals (Basel). 2024; 17(5).

PMID: 38794144 PMC: 11124340. DOI: 10.3390/ph17050574.

References
1.
Zhang L, Li J, Tian D, Sun L, Wang X, Tian M . Theranostic combinatorial drug-loaded coated cubosomes for enhanced targeting and efficacy against cancer cells. Cell Death Dis. 2020; 11(1):1. PMC: 6946659. DOI: 10.1038/s41419-019-2182-0. View

2.
Hashemi S, Balouchi A, Al-Mawali A, Rafiemanesh H, Rezaie-Keikhaie K, Bouya S . Health-related quality of life of breast cancer patients in the Eastern Mediterranean region: a systematic review and meta-analysis. Breast Cancer Res Treat. 2019; 174(3):585-596. DOI: 10.1007/s10549-019-05131-0. View

3.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

4.
Momenimovahed Z, Salehiniya H . Epidemiological characteristics of and risk factors for breast cancer in the world. Breast Cancer (Dove Med Press). 2019; 11:151-164. PMC: 6462164. DOI: 10.2147/BCTT.S176070. View

5.
Najjary S, Mohammadzadeh R, Mokhtarzadeh A, Mohammadi A, Baghbanzadeh Kojabad A, Baradaran B . Role of miR-21 as an authentic oncogene in mediating drug resistance in breast cancer. Gene. 2020; 738:144453. DOI: 10.1016/j.gene.2020.144453. View